Mainz Biomed (MYNZ) Invested Capital (2020 - 2025)
Historic Invested Capital for Mainz Biomed (MYNZ) over the last 5 years, with Q4 2024 value amounting to $7.1 million.
- Mainz Biomed's Invested Capital fell 1283.49% to $7.1 million in Q4 2024 from the same period last year, while for Jun 2025 it was $96474.0, marking a year-over-year decrease of 2525.05%. This contributed to the annual value of $7.1 million for FY2024, which is 1283.49% down from last year.
- As of Q4 2024, Mainz Biomed's Invested Capital stood at $7.1 million, which was down 1283.49% from $32140.0 recorded in Q2 2024.
- In the past 5 years, Mainz Biomed's Invested Capital registered a high of $14.2 million during Q4 2022, and its lowest value of -$2.7 million during Q4 2020.
- Moreover, its 5-year median value for Invested Capital was $52772.5 (2022), whereas its average is $3.3 million.
- Its Invested Capital has fluctuated over the past 5 years, first surged by 34012.27% in 2021, then crashed by 5527.9% in 2023.
- Over the past 5 years, Mainz Biomed's Invested Capital (Quarter) stood at -$2.7 million in 2020, then soared by 340.12% to $6.4 million in 2021, then surged by 120.11% to $14.2 million in 2022, then tumbled by 42.79% to $8.1 million in 2023, then dropped by 12.83% to $7.1 million in 2024.
- Its Invested Capital was $7.1 million in Q4 2024, compared to $32140.0 in Q2 2024 and $8.1 million in Q4 2023.